Tata Consultancy Services Ltd — Q3 FY24
TCS reported Q3 FY24 revenue of INR 63,583 crore, up 4% YoY, with operating margin expanding 70 bps sequentially to 25%.
✓ Verified against BSE filing
Bear Cases vs Reality
The market's top concerns about TCS, tested against this quarter's numbers.
North America revenue decline signals prolonged weakness
North America revenue declined 3% YoY in Q3, continuing a trend of weakness. Analysts have questioned when this key market will recover, and management has not provided a timeline.
-3% YoY
North America revenue declined 3% YoY in Q3, worse than the flat growth expected. This confirms the bear case that weakness persists, with no recovery in sight.
Strong deal wins not translating to revenue growth
Despite $8.1B in deal wins, revenue growth remains muted at 4% YoY. Analysts have flagged that deal conversion is slow due to client reprioritization, and this disconnect persists.
Revenue growth 4% YoY; Deal TCV $8.1B
Revenue grew only 4% YoY despite $8.1B in deal wins, indicating continued slow conversion. The bear case remains valid as the disconnect between TCV and revenue persists.
BFSI weakness continues with no recovery timeline
BFSI revenue declined 3% YoY in Q3, and management could not provide a timeline for recovery. This sector is a key driver, and its weakness is a major concern.
-3% YoY
BFSI revenue declined 3% YoY, consistent with prior quarters. Management's lack of recovery timeline keeps this bear case alive.
Headcount decline signals demand softness
Headcount declined by 5,600 in Q3, following a decline of 6,000+ in Q2. This could indicate lower demand or utilization, despite management attributing it to past hiring.
-5,600
Headcount fell by 5,600 in Q3, continuing the decline from Q2. This supports the bear case that demand is soft, as hiring is a leading indicator.
GenAI revenue impact remains negligible
GenAI is still in early stages with only four production deployments. Management could not provide a timeline for meaningful revenue contribution, raising doubts about its near-term impact.
4
Only four GenAI deployments in production, down from 250+ engagements in Q2. This shows limited progress, keeping the bear case alive.